XML 19 R17.htm IDEA: XBRL DOCUMENT v2.3.0.15
Net Earnings Per Common Share
9 Months Ended
Sep. 30, 2011
Net Earnings Per Common Share [Abstract] 
Net Earnings Per Common Share

Net Earnings Per Common Share—The following table sets forth the computation of basic and diluted net earnings per common share for the periods indicated (amounts in thousands, except per share amounts).

 

     Three Months Ended 
September 30,
     Nine Months Ended 
September 30,
 
     2011      2010      2011      2010  
     (In thousands, except per share data)  

Basic

           

Average common shares outstanding

     31,873         32,431         31,999         32,389   

Net earnings

   $ 12,800       $ 15,598       $ 30,915       $ 18,093   

Net earnings per common share

   $ 0.40       $ 0.48       $ 0.97       $ 0.56   

Diluted

           

Average common shares outstanding

     31,873         32,431         31,999         32,389   

Stock options and awards

     251         93         382         99   

Shares related to convertible debt

     67         0         330         41   
  

 

 

    

 

 

    

 

 

    

 

 

 

Average common shares assuming dilution

     32,191         32,524         32,711         32,529   

Net earnings

   $ 12,800       $ 15,598       $ 30,915       $ 18,093   

Net earnings per common share

   $ 0.40       $ 0.48       $ 0.95       $ 0.56   

At September 30, 2011, 2,760,783 and 2,510,535 shares were excluded from the average common shares assuming dilution for the three and nine months ended September 30, 2011, respectively, as they were anti-dilutive since the majority of the anti-dilutive shares were granted at an exercise price of $41.87, which was higher than the Company's average stock prices of $27.18 and $29.79 for the three and nine months ended September 30, 2011, respectively. At September 30, 2010, 3,877,362 and 3,425,015 shares were excluded from the average common shares assuming dilution for the three and nine months ended September 30, 2010 as they were anti-dilutive since the majority of the anti-dilutive shares were granted at an exercise price of $25.24, which was higher than the Company's stock prices of $23.28 and $24.99 for the three and nine months ended September 30, 2010, respectively.

The Company included the impact of 67,000 and 330,000 shares, for the three and nine months ended September 30, 2011, respectively, necessary to settle the conversion spread related to the Company's 4.125% Senior Subordinated Convertible Debentures due 2027 compared to zero and 41,000 shares for the three and nine months ended September 30, 2010, respectively. This is attributable to the Company's average stock price during the first three and nine months of both years being greater than the conversion price of $24.79, established under the indenture governing the convertible debentures. The dilutive impact of the convertible debt on diluted earnings per share is directly affected by changes in the Company's stock price and thus increased dilution in the future is possible if the Company's stock price increases.